Boehringer Ingelheim

APIE Therapeutics, Inc. is a cutting-edge biopharmaceutical company based in Cary, NC, dedicated to improving patient health outcomes. With a focus on developing therapeutic drugs that enhance the body's natural repair and regeneration process, APIE aims to address debilitating diseases caused by the breakdown of optimal repair and healthy wound-healing processes. Through their pioneering work in stem cell research, APIE Therapeutics is at the forefront of developing novel therapeutics that stimulate resident stem cells to repair and regenerate damaged vascular tissue in chronic diseases. With a highly experienced team and exclusive worldwide intellectual property rights, APIE is poised to deliver first-in-class therapies and create significant value in the field of regenerative medicine.Generated from the website

Nephro Genex Inc is a reliable online pharmacy based in Raleigh, NC, offering a wide range of medications and pharmacy products delivered straight to customers' doors. With a focus on convenience and affordability, they provide professional assistance in purchasing medicines, offer expert advice, and ensure the availability of quality products from trusted global suppliers. Committed to the health and satisfaction of their customers, Nephro Genex Inc stands out as a safe distributor by maintaining reasonable prices, providing a physical address, and only selling prescription drugs with proper verification. Their online catalog features a comprehensive range of medications, herbal supplements, medical cosmetics, and equipment, making it easy for customers to find what they need. With positive reviews from customers worldwide, Nephro Genex Inc is a trusted source for reliable and genuine pharmaceutical products.Generated from the website

Critical Therapeutics is a biopharmaceutical company focused on the discovery, development and commercialization of products for respiratory, inflammatory and critical care diseases. The company owns rights to the asthma drug ZYFLO, or zileuton tablets, in addition to other formulations of zileuton throughout the world. ZYFLO is one of the only five lipoxygenase inhibitors approved for marketing by the Untied States Food and Drug Administration and is indicated for the prevention and chronic treatment of asthma in adults and children 12 years of age and older. Critical Therapeutics s commercialization effort for ZYFLO is done with nearly 80 people on the company s specialty sales force. Headquartered in Lexington, Mass., Critical Therapeutics is a privately owned company.